Deep Biotech Solutions

Deep Biotech Solutions is a biotechnology company that provides personalized molecular biology and genomic services to researchers. The company utilizes advanced technologies such as CRISPR/Cas9 for genetic modifications, next-generation sequencing (NGS)—including whole genome, whole transcriptome, and SMRT long-read sequencing—and molecular cloning. Their approach integrates deep neural network-based machine learning into their analysis processes, aiming to provide researchers with tailored, actionable data rather than just raw sequencing results. The company distinguishes itself by offering comprehensive scientific documentation with its products, covering experimental procedures, materials, and quality control, which serves as a resource for drafting scientific manuscripts or patent applications.

Operating as a contract research organization (CRO), the company serves as a comprehensive hub for complex experimental projects, such as drug evaluation or gene expression profiling on genetically modified cell lines. By centralizing services including gene synthesis, bioinformatics, and specialized assays, the company enables researchers to streamline their workflows and focus on analyzing results. Their team consists of experienced academic and university researchers, and they emphasize the delivery of rapid, ultra-personalized solutions designed to advance scientific investigations in biotechnology and healthcare.